Skip to main content

Seagen Inc.

SGENDelisted Dec 14, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001060736

Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.

Holders of 5% or more of SGEN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Seagen Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Seagen Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

11 Schedule 13D and 13G filings on Seagen Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SGEN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 10, 2022Baker Bros. Advisors LP13D/AOld format–––SEC
Feb 11, 2022Capital International Investors13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13GOld format–––SEC
May 18, 2021Baker Bros. Advisors LP13D/AOld format–––SEC
Feb 16, 2021Capital International Investors13G/AOld format–––SEC
Feb 16, 2021Capital International Investors13G/AOld format–––SEC
Feb 16, 2021Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2021Wellington Management Group LLP13G/AOld format–––SEC
Feb 1, 20218:17 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Seagen Inc. shares.

No Form 144 notices for Seagen Inc. are on file.